4/A//SEC Filing
Khosrovi Behzad 4/A
Accession 0001140361-10-045861
CIK 0001389545other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:56 PM ET
Size
6.0 KB
Accession
0001140361-10-045861
Insider Transaction Report
Form 4/AAmended
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2007-12-14+37,500→ 237,500 totalExercise: $3.56From: 2008-12-14Exp: 2017-12-13→ Common Stock (37,500 underlying)
Footnotes (1)
- [F1]Original Form 4 filed on December 18, 2007. This amended form is being filed to correct the total securities following reported transaction under Table II, Item 9 which should be 237,500 not 37,500.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001410078
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:56 PM ET
- Size
- 6.0 KB